These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
439 related articles for article (PubMed ID: 22355676)
21. Clinical Impact of KRAS and GNAS Analysis Added to CEA and Cytology in Pancreatic Cystic Fluid Obtained by EUS-FNA. Faias S; Duarte M; Albuquerque C; da Silva JP; Fonseca R; Roque R; Dias Pereira A; Chaves P; Cravo M Dig Dis Sci; 2018 Sep; 63(9):2351-2361. PubMed ID: 29796909 [TBL] [Abstract][Full Text] [Related]
22. A case of ectopic pancreas of the stomach accompanied by intraductal papillary mucinous neoplasm with GNAS mutation. Nambu N; Yamasaki T; Nakagomi N; Kumamoto T; Nakamura T; Tamura A; Tomita T; Miwa H; Shinohara H; Hirota S World J Surg Oncol; 2021 Oct; 19(1):309. PubMed ID: 34674710 [TBL] [Abstract][Full Text] [Related]
23. Molecular biomarkers for progression of intraductal papillary mucinous neoplasm of the pancreas. Kuboki Y; Shimizu K; Hatori T; Yamamoto M; Shibata N; Shiratori K; Furukawa T Pancreas; 2015 Mar; 44(2):227-35. PubMed ID: 25423558 [TBL] [Abstract][Full Text] [Related]
24. Loss of Pten and Activation of Kras Synergistically Induce Formation of Intraductal Papillary Mucinous Neoplasia From Pancreatic Ductal Cells in Mice. Kopp JL; Dubois CL; Schaeffer DF; Samani A; Taghizadeh F; Cowan RW; Rhim AD; Stiles BL; Valasek M; Sander M Gastroenterology; 2018 Apr; 154(5):1509-1523.e5. PubMed ID: 29273451 [TBL] [Abstract][Full Text] [Related]
25. GNAS mutation detection in circulating cell-free DNA is a specific predictor for intraductal papillary mucinous neoplasms of the pancreas, especially for intestinal subtype. Hata T; Mizuma M; Motoi F; Omori Y; Ishida M; Nakagawa K; Hayashi H; Morikawa T; Kamei T; Furukawa T; Unno M Sci Rep; 2020 Oct; 10(1):17761. PubMed ID: 33082481 [TBL] [Abstract][Full Text] [Related]
26. GNAS but Not Extended RAS Mutations Spectrum are Associated with a Better Prognosis in Intraductal Pancreatic Mucinous Neoplasms. Gaujoux S; Parvanescu A; Cesaretti M; Silve C; Bieche I; Rebours V; Lévy P; Sauvanet A; Cros J Ann Surg Oncol; 2019 Aug; 26(8):2640-2650. PubMed ID: 31025231 [TBL] [Abstract][Full Text] [Related]
27. A GNAS mutation found in pancreatic intraductal papillary mucinous neoplasms induces drastic alterations of gene expression profiles with upregulation of mucin genes. Komatsu H; Tanji E; Sakata N; Aoki T; Motoi F; Naitoh T; Katayose Y; Egawa S; Unno M; Furukawa T PLoS One; 2014; 9(2):e87875. PubMed ID: 24498386 [TBL] [Abstract][Full Text] [Related]
28. McCune Albright syndrome is a genetic predisposition to intraductal papillary and mucinous neoplasms of the pancreas associated pancreatic cancer in relation with GNAS somatic mutation - a case report. Gaujoux S; Pasmant E; Silve C; Mehsen-Cetre N; Coriat R; Rouquette A; Douset B; Prat F; Leroy K Medicine (Baltimore); 2019 Dec; 98(50):e18102. PubMed ID: 31852070 [TBL] [Abstract][Full Text] [Related]
29. GNAS and KRAS mutational analyses of intraductal papillary neoplasms of the pancreas and bile duct developing in the same individual: A case report. Date K; Ohtsuka T; Fujimoto T; Gotoh Y; Nakashima Y; Kimura H; Matsunaga T; Mori Y; Mochidome N; Miyazaki T; Oda Y; Tanaka M; Nakamura M Pancreatology; 2015; 15(6):713-6. PubMed ID: 26506885 [TBL] [Abstract][Full Text] [Related]
30. Impact of next-generation sequencing on the clinical diagnosis of pancreatic cysts. Jones M; Zheng Z; Wang J; Dudley J; Albanese E; Kadayifci A; Dias-Santagata D; Le L; Brugge WR; Fernandez-del Castillo C; Mino-Kenudson M; Iafrate AJ; Pitman MB Gastrointest Endosc; 2016 Jan; 83(1):140-8. PubMed ID: 26253016 [TBL] [Abstract][Full Text] [Related]
31. Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development. Wu J; Matthaei H; Maitra A; Dal Molin M; Wood LD; Eshleman JR; Goggins M; Canto MI; Schulick RD; Edil BH; Wolfgang CL; Klein AP; Diaz LA; Allen PJ; Schmidt CM; Kinzler KW; Papadopoulos N; Hruban RH; Vogelstein B Sci Transl Med; 2011 Jul; 3(92):92ra66. PubMed ID: 21775669 [TBL] [Abstract][Full Text] [Related]
32. Intraductal Papillary Mucinous Neoplasms Arise From Multiple Independent Clones, Each With Distinct Mutations. Fischer CG; Beleva Guthrie V; Braxton AM; Zheng L; Wang P; Song Q; Griffin JF; Chianchiano PE; Hosoda W; Niknafs N; Springer S; Dal Molin M; Masica D; Scharpf RB; Thompson ED; He J; Wolfgang CL; Hruban RH; Roberts NJ; Lennon AM; Jiao Y; Karchin R; Wood LD Gastroenterology; 2019 Oct; 157(4):1123-1137.e22. PubMed ID: 31175866 [TBL] [Abstract][Full Text] [Related]
33. Pancreatobiliary-type intraductal papillary mucinous neoplasm of the pancreas may have 2 subtypes with distinct clinicopathologic and genetic features. Shimizu T; Akita M; Sofue K; Toyama H; Itoh T; Fukumoto T; Zen Y Hum Pathol; 2019 Sep; 91():26-35. PubMed ID: 31175918 [TBL] [Abstract][Full Text] [Related]
34. KRAS/GNAS-testing by highly sensitive deep targeted next generation sequencing improves the endoscopic ultrasound-guided workup of suspected mucinous neoplasms of the pancreas. Schmitz D; Kazdal D; Allgäuer M; Trunk M; Vornhusen S; Nahm AM; Doll M; Weingärtner S; Endris V; Penzel R; Kirchner M; Brandt R; Neumann O; Sültmann H; Budczies J; Kienle P; Magdeburg R; Hetjens S; Schirmacher P; Bergmann F; Rudi J; Stenzinger A; Volckmar AL Genes Chromosomes Cancer; 2021 Jul; 60(7):489-497. PubMed ID: 33686791 [TBL] [Abstract][Full Text] [Related]
35. Distinction of Invasive Carcinoma Derived From Intraductal Papillary Mucinous Neoplasms From Concomitant Ductal Adenocarcinoma of the Pancreas Using Molecular Biomarkers. Tamura K; Ohtsuka T; Date K; Fujimoto T; Matsunaga T; Kimura H; Watanabe Y; Miyazaki T; Ohuchida K; Takahata S; Ishigami K; Oda Y; Mizumoto K; Nakamura M; Tanaka M Pancreas; 2016 Jul; 45(6):826-35. PubMed ID: 26646266 [TBL] [Abstract][Full Text] [Related]
36. Mutant GNAS drives pancreatic tumourigenesis by inducing PKA-mediated SIK suppression and reprogramming lipid metabolism. Patra KC; Kato Y; Mizukami Y; Widholz S; Boukhali M; Revenco I; Grossman EA; Ji F; Sadreyev RI; Liss AS; Screaton RA; Sakamoto K; Ryan DP; Mino-Kenudson M; Castillo CF; Nomura DK; Haas W; Bardeesy N Nat Cell Biol; 2018 Jul; 20(7):811-822. PubMed ID: 29941929 [TBL] [Abstract][Full Text] [Related]
37. KRAS Mutations With No GNAS Mutations in an Intraductal Papillary Mucinous Neoplasm: Are There Common Pathways With Pancreatic Ductal Adenocarcinoma? Lessons From an Extended IPMN, Covering the Entire Pancreas. Tampakis A; Tampaki EC; Posabella A; Zettl A; Kouraklis G; von Flüe M; Guenin MO Pancreas; 2017 Jan; 46(1):e5-e7. PubMed ID: 27977634 [No Abstract] [Full Text] [Related]
38. Tracking the Clonal Evolution of Adenosquamous Carcinoma, a Rare Variant of Intraductal Papillary Mucinous Neoplasm of the Pancreas. Matsuzaka S; Karasaki H; Ono Y; Ogata M; Oikawa K; Tamakawa S; Chiba S; Muraki M; Yokochi T; Funakoshi H; Kono T; Nagashima K; Mizukami Y Pancreas; 2016 Jul; 45(6):915-8. PubMed ID: 27295533 [TBL] [Abstract][Full Text] [Related]
39. Long-term Risk of Malignancy in Branch-Duct Intraductal Papillary Mucinous Neoplasms. Oyama H; Tada M; Takagi K; Tateishi K; Hamada T; Nakai Y; Hakuta R; Ijichi H; Ishigaki K; Kanai S; Kogure H; Mizuno S; Saito K; Saito T; Sato T; Suzuki T; Takahara N; Morishita Y; Arita J; Hasegawa K; Tanaka M; Fukayama M; Koike K Gastroenterology; 2020 Jan; 158(1):226-237.e5. PubMed ID: 31473224 [TBL] [Abstract][Full Text] [Related]
40. Treatment strategy for main duct intraductal papillary mucinous neoplasms of the pancreas based on the assessment of recurrence in the remnant pancreas after resection: a retrospective review. Tamura K; Ohtsuka T; Ideno N; Aso T; Shindo K; Aishima S; Ohuchida K; Takahata S; Ushijima Y; Ito T; Oda Y; Mizumoto K; Tanaka M Ann Surg; 2014 Feb; 259(2):360-8. PubMed ID: 23989056 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]